Pause is the second imposed by drugmakers racing to develop coronavirus vaccine; new study suggests COVID-19 patients remain vulnerable to reinfection/
Actualités similaires
Articles similaires à Johnson & Johnson Pauses Late-Stage COVID-19 Vaccine Trial After Volunteer Becomes Sick